Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.
An important cause of Alzheimer's disease inflammation has recently been linked to a gene that is prevalent in the brain's cleaning cells, called microglia, according to a recent study. The discovery might offer a brand-new area of focus for treatments of the incurable disease.
Researchers found lung cancer screenings useful to increase survival rate of cancer patients. Early-stage lung cancer is detected by low-dose computed tomography (CT) screening.
The study discovered new treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.
Researchers have identified therapies that can help patients with multiple myeloma blood cancer who try an immunotherapy known as CAR-T only to find their cancer returning afterwards.
A novel metric that estimates our "burden," or cumulative exposure, to a family of thousands of synthetic chemicals that we encounter in everyday life with potentially adverse health impacts, has been created by a team of researchers at Mount Sinai.
Washington [US], September 9 (ANI): Scientists at Mount Sinai's Icahn School of Medicine, the National Center for Advancing Translational Sciences (NCATS), and other institutions have reversed the effects of several life-threatening inherited neurodegenerative diseases known as lysosomal storage disorders (LSDs) in patient cells and mice.
Washington [US], September 2 (ANI): Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two different antigens at the same time -- they are meant to enhance the immune system's destruction of tumour cells.
Washington [US], June 26 (ANI): A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 per cent.
Washington [US], May 23 (ANI): In multiple studies from eight cohorts across the United States, a group of researchers accelerated the collection of essential data to answer questions about the immune response needed for long-term protection against SARSCoV2.